| 前收市價 | 23.86 |
| 開市 | 24.14 |
| 買盤 | 24.01 x 100 |
| 賣出價 | 24.07 x 600 |
| 今日波幅 | 23.92 - 24.48 |
| 52 週波幅 | 22.01 - 33.71 |
| 成交量 | |
| 平均成交量 | 2,062,603 |
| 市值 | 4.07B |
| Beta 值 (5 年，每月) | 0.55 |
| 市盈率 (最近 12 個月) | 7.16 |
| 每股盈利 (最近 12 個月) | 3.36 |
| 業績公佈日 | 2024年7月22日 - 2024年7月26日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 34.45 |
Investor's Business DailyThe Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
ZacksAlkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Alkermes' (ALKS) earnings and revenues miss first-quarter 2024 estimates. However, revenues rise year over year on strong proprietary product sales.
ZacksAlkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
